5/16/2022Kelun Out-licenses Anticancer Drug Candidate to MSD in $1.4B Deal

5/16/2022Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...

5/13/2022Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...

5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021

5/13/2022SMEI: Top 20 Pharma Cos by Hospital Drug Sales in 2021

5/12/2022Henlius and Eurofarma Entered into a License Deal for Three Henlius P...

5/12/2022Merck KGaA Warns of Volatile 2022 Thanks to War in Ukraine and Fresh C...

5/12/2022China Resources in Talks to Take Sihuan Pharma Private At $3B Valuatio...

5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...

5/11/2022NMPA Issues the 14th FYP for Drug Regulatory Network Safety and IT Bui...

5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021

5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation

5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021

5/6/2022Orion Enters into Exclusive Deal with Jemincare for Novel Non-Opioid D...

5/6/2022Drug R&D and Product Registration News Digest May 2022 (1)

5/6/2022Recent Executive Moves

5/4/2022BeiGene/Amgen Granted CN Conditional Approval of BLINCYTO (Blinatumo...

5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

5/2/2022China Continues to Drop Reimbursements via DIP system: PBM

5/2/2022U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...

5/2/2022Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...

4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...

4/29/2022NHSA and NHC Issue Notice to Improve National 6th VBP (Insulin Program...

4/29/2022Recent Executive Moves

4/29/2022Financial-related Company News Digest

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China

Page:78/367 Total number of articles:10998: [First][<<] [76] [77] [78] [79] [80] [>>] [End]